Avalyn Pharma expands leased space under Boston deal.
Avalyn Pharma and CRISPR Therapeutics agreed to expand the total leased area to approximately 13,700 square feet. This amendment enhances operations at the Boston facility.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day